ArticleCureus2026
Measles Outbreak in Children: Experience of the Children's Hospital of Rabat (2024-2025).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMeasles remains a highly contagious viral disease and a persistent public health challenge despite the availability of effective vaccination. Since late 2023, Morocco has experienced a resurgence of measles cases, highlighting gaps in vaccination coverage and surveillance. This study aimed to describe the epidemiological, clinical, and outcome characteristics of children hospitalized for measles during the 2024-2025 outbreak at the Children's Hospital of Rabat and to compare the occurrence of complications according to vaccination status and age group. MATERIALS AND
methodsA retrospective hospital-based observational study was conducted in the Department of Pediatric Pneumo-Allergology and Infectious Diseases at the Children's Hospital of Rabat between February 1, 2024, and September 1, 2025, corresponding to the measles outbreak period. Sociodemographic, clinical, paraclinical, and outcome data were extracted from medical records. Categorical variables were summarized as frequencies and percentages. Continuous variables were summarized using medians and interquartile ranges, given the skewed age distribution. Comparisons were performed using the chi-square or Fisher's exact test.
resultsA total of 587 children were included, with a median age of 15 months; 67% were infants. Boys accounted for 57% of cases, and 56% of children lived in rural areas. Overall, 61% were unvaccinated, 16% were partially vaccinated, and 23% were fully vaccinated. Complications occurred in 56% of patients, predominantly respiratory (54%). Complications were more frequently observed among children who were not fully vaccinated compared to fully vaccinated children.
conclusionThis study provides a descriptive hospital-based overview of pediatric measles cases requiring admission during the 2024-2025 outbreak. Severe complications and in-hospital mortality were frequently observed among hospitalized children, particularly among younger infants. These findings are limited to hospitalized cases and do not allow inference regarding vaccine effectiveness, outbreak dynamics, or population-level disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.